An ideal choice for high-frequency testing—enabling fast, trusted COVID-19 test results from raw saliva

Thermo Fisher Scientific continues to provide the gold standard of testing with our evolved Emergency Use Authorized (EUA) PCR-based TaqPath COVID-19 2.0 tests, which were developed to help laboratories quickly diagnose COVID-19 caused by SARS-CoV-2 infection.

The TaqPath COVID-19 Fast PCR Combo Kit 2.0 was designed with an innovative, multi-target assay design to compensate for current and future emerging SARS-CoV-2 mutations. Our advanced PCR-based test enables fast, trusted COVID-19 test results from raw saliva, making it an ideal choice for high-frequency testing.

Features of the TaqPath COVID-19 Fast PCR 2.0 Combo Kit 2.0 include:

  • Compatible with raw saliva (no preservatives) for symptomatic and asymptomatic individuals
  • Utilizes human sample confirmation RNase P gene as an internal control
  • Go from sample to results in ~2 hours (bypassing RNA extraction)

Fill out the form and read the poster and application note to learn more.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.



For Emergency Use Authorization. For in vitro diagnostics. For Prescription use only.